HLA DPA1, DPB1 alleles and haplotypes contribute to the risk associated with type 1 diabetes: Analysis of the type 1 diabetes genetics consortium families

Diabetes

Volumn 59, Issue 8, 2010, Pages 2055-2062

  Varney, Michael D ^a   Valdes, Ana Maria ^b   Carlson, Joyce A ^c   Noble, Janelle A ^d   Tait, Brian D ^a   Bonella, Persia ^d   Lavant, Eva ^c   Fear, Anna Lisa ^d   Louey, Anthony ^a   Moonsamy, Priscilla ^e   Mychaleckyj, Josyf C ^f   Erlich, Henry ^d,e  

^a AUSTRALIAN RED CROSS BLOOD SERVICE   (Australia)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c LUND UNIVERSITY HOSPITAL   (Sweden)

^d CHILDREN S HOSPITAL OAKLAND RESEARCH INSTITUTE   (United States)

^e ROCHE MOLECULAR SYSTEMS   (United States)

^f UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HLA DP ANTIGEN; HLA DPA1 ANTIGEN; HLA DPB1 ANTIGEN; HLA DQA1 ANTIGEN; HLA DQB1 ANTIGEN; HLA DR ANTIGEN; UNCLASSIFIED DRUG;

ARTICLE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC RISK; HAPLOTYPE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR;

DIABETES MELLITUS, TYPE 1; EUROPEAN CONTINENTAL ANCESTRY GROUP; FAMILY; GENOTYPE; HAPLOTYPES; HLA ANTIGENS; HLA-DP ANTIGENS; HUMANS; RISK FACTORS;

EID: 77955389016     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db09-0680     Document Type: Article

References (46)

1. Todd, JA. Genetic control of autoimmunity in type 1 diabetes. Immun-Today 1990;11:122-129
2. Risch N. Assessing the role of HLA-linked and unlinked determinants of disease. Am J Hum Genet 1987;40:1-14
3. Gillespie KM, Bain SC, Barnett AH, Bingley PJ, Christie MR, Gill GV, Gale EA. The rising incidence of childhood type 1 diabetes and reduced contribution of high-risk HLA haplotypes. Lancet 2004;364:1699-1700
4. Fourlanos S, Varney MD, Tait BD, Morahan G, Honeyman MC, Colman PG, Harrison LC. The rising incidence of type 1 diabetes is accounted for by cases with lower risk human leucocyte antigen genotypes. Diabetes Care 2008;31:1546-1549
5. Concannon P, Erlich HA, Julier C, Morahan G, Nerup J, Pociot F, Todd JA, Rich SS; Type 1 Diabetes Genetics Consortium. Type 1 diabetes evidence for susceptibility loci from four genome-wide linkage scans in 1,435 multiplex families. Diabetes 2005;54:2995-3001
6. Concannon P, Onengut-Gumuscu S, Todd JA, Smyth DJ, Pociot F, Bergholdt R, Akolkar B, Erlich HA, Hilner JE, Julier C, Morahan G, Nerup J, Nierras CR, Chen WM, Rich SS; Type 1 Diabetes Genetics Consortium: A human type 1 diabetes susceptibility locus maps to chromosome 21q22.3. Diabetes 2008;57:2858-2861
7. Erlich H, Valdes AM, Noble J, Carlson JA, Varney M, Concannon P, Mychaleckyj JC, Todd JA, Bonella P, Fear AL, Lavant E, Louey A, Moonsamy P; Type 1 Diabetes Genetics Consortium. HLA DR-DQ haplotypes and genotypes and type 1 diabetes risk: analysis of the Type 1 Diabetes Genetics Consortium families. Diabetes 2008;57:1084-1092
8. Bondinas GP, Moustakas AK, Papadopoulos GK. The spectrum of HLA-DQ and HLA-DR alleles, 2006: a listing correlating sequence and structure with function. Immunogenetics 2007;59:539-553
9. Shaw S, Johnson AH, Shearer GM. Evidence for a new segregant series of B cell antigens that are encoded in the HLA-D region and that stimulate secondary allogenic proliferative and cytotoxic responses. J Exp Med 1980;152:565-580
10. Pawelec G, Bühring HJ. Expression of MHC class II epitopes on human T lymphocyte clones. Cell Immunol 1990;127:520-526
11. Cesbron A, Moreau P, Milpied N, Harousseau JL, Muller JY, Bignon JD. Crucial role of the third and fourth hypervariable regions of HLA-DPB1 allelic sequences in the mixed lymphocyte reaction. Hum Immunol 1992; 33:202-207
12. Nicholson I, Varney M, Kanaan C, Grigg A, Szer J, Tiedemann K, Tait BD. Alloresponses to HLA-DP detected in the primary MLR-correlation with a single amino acid difference. Hum Immunol 1997;55:163-169
13. Nomura N, Ota M, Kato S, Inoko M, Tsuji K. Severe acute graft versus host disease by HLA-DPB1 disparity in recombinant family of bone marrow transplantation between serologically HLA identical siblings: an application of the polymerase chain reaction-restriction fragment length polymorphism method. Hum Immunol 1991;32:261-268
14. Richeldi L, Sorrentino R, Saltini C. HLA-DPB1 Glutamate 69: a genetic marker of beryllium disease. Science 1993;262:242-244
15. Baisch JM, Capra JD. Analysis of HLA genotypes and susceptibility to insulin-dependent diabetes mellitus: association maps telomeric to HLA-DP. Scand J Immunol 1992;36:331-340
16. Tait BD, Harrison LC, Drummond BP, Stewart V, Varney MD, Honeyman MC. HLA antigens and age at diagnosis of insulin-dependent diabetes mellitus. Hum Immunol 1995;42:116-122
17. Balducci-Silano PL, Layrisse ZE. HLA-DP and susceptibility to insulin-dependent diabetes mellitus in an ethnically mixed population. Associations with other HLA-alleles. J Autoimmun 1995;8:425-437
18. Erlich HA, Rotter JI, Chang JD, Shaw SJ, Raffel LJ, Klitz W, Bugawan TL, and Zeidler A. Association of HLA-DPB1*0301 with IDDM in Mexican-Americans. Diabetes 1996;45:610-614
19. Nishimaki K, Kawamura T, Inada H, Yagawa K, Nose Y, Nabeya N, Isshiki G, Tatsumi N, Niihira S. HLA DPB1*0201 gene confers disease susceptibility in Japanese with childhood onset type I diabetes, independent of HLA-DR and DQ genotypes. Diabetes Res Clin Pract 2000;47:49-55
20. Noble JA, Valdes AM, Thomson G, Erlich HA. The HLA class II locus DPB1 can influence susceptibility to type 1 diabetes. Diabetes 2000;49:121-125
21. Cucca F, Lampis R, Congia M, Angius E, Nutland S, Bain SC, Barnett AH, Todd JA. A correlation between the relative predisposition of MHC class II alleles to type 1 diabetes and the structure of their proteins. Hum Mol Genet 2001;10:2025-2037
22. Al-Hussein KA, Rama NR, Ahmad M, Rozemuller E, Tilanus MG. HLA-DPB1* 0401 is associated with dominant protection against type 1 diabetes in the general Saudi population and in subjects with a high-risk DR/DQ haplotype. Eur J Immunogenet 2003;30:115-119
23. Cruz TD, Valdes AM, Santiago A, Frazer de Llado T, Raffel LJ, Zeidler A, Rotter JI, Erlich HA, Rewers M, Bugawan T, Noble JA. DPB1 alleles are associated with type 1 diabetes susceptibility in multiple ethnic groups. Diabetes 2004;53:2158-2163
24. Johansson S, Lie BA, Pociot F, Nerup J, Cambon-Thomsen A, Kockum I, Thorsby E, Undlien DE. HLA associations in type 1 diabetes: DPB1 alleles may act as markers of other HLA-complex susceptibility genes. Tissue Antigens 2003;61:344-351
25. Mbanya JC, Sobngwi E, Mbanya DN. HLA-DRB1, -DQA1, -DQB1 and DPB1 susceptibility alleles in Cameroonian type 1 diabetes patients and controls. Eur J Immunogenet 2001;28:459-462
26. Begovich AB, McClure GR, Suraj VC, Helmuth RC, Fildes N, Bugawan TL, Erlich HA, Klitz W. Polymorphism, recombination, and linkage disequilibrium within the HLA class II region. J Immunol 1992;148:249-258
27. Rich SS, Concannon P, Erlich H, Julier C, Morahan G, Nerup J, Pociot F, Todd JA; The Type 1 Diabetes Genetics Consortium. Ann N Y Acad Sci 2006;1079:1-8
28. Mychaleckyj JC, Noble JA, Moonsamy PV, Carlson J, Varney MD, Post J, Helmberg W, Pierce J, Bonella P, Fear AL, Lavant E, Louey A, Boyle S, Lane J, Sali P, Kim S, Rappner R, Williams DT, Perdue LH, Reboussin D, Tait BD, Akolkar B, Hilner JE, Steffes MW, Erlich HA. HLA genotyping in The International Type 1 Diabetes Genetics Consortium (T1DGC). Clinical Trials (submitted)
29. Thomson G. Mapping disease genes: family-based association studies. Am J Hum Genet 1995;57:487-498
30. Thomson G. HLA DR antigens and susceptibility to insulin-dependent diabetes mellitus. Am J Hum Genet 1984 Nov;36(6):1309-1317
31. Noble JA, Valdes AM, Bugawan TL, Apple RJ, Thomson G, Erlich HA. The HLA class I A locus affects susceptibility to type 1 diabetes. Hum Immunol 2002;63(8):657
32. Nejentsev S, Howson JM, Walker NM, Szeszko J, Field SF, Stevens HE, Reynolds P, Hardy M, King E, Masters J, Hulme J, Maier LM, Smyth D, Bailey R, Cooper JD, Ribas G, Campbell RD, Clayton DG, Todd JA; Wellcome Trust Case Control Consortium. Localization of type 1 diabetes susceptibility to the MHC class I genes HLA-B and HLA-A. Nature 2007;450:887-892
33. Howson JM, Walker NM, Clayton D, Todd JA; Type 1 Diabetes Genetics Consortium. Confirmation of HLA class II independent type 1 diabetes associations in the major histocompatibility complex including HLA-B and HLA-A. Diabetes Obes Metab 2009;11 Suppl. 1:31-45
34. Payami H, Joe S, Farid NR, Stenszky V, Chan SH, Yeo PP, Cheah JS, Thomson G. Relative predispositional effects (RPEs) of marker alleles with disease: HLA-DR alleles and Graves disease. Am J Hum Genet 1989;45: 541-546
35. Bilbao JR, Calvo B, Aransay AM, Martin-Pagola A, Perez de Nanclares G, Aly TA, Rica I, Vitoria JC, Gaztambide S, Noble J, Fain PR, Awdeh ZL, Alper CA, Castaño L. Conserved extended haplotypes discriminate HLA-DR3-homozygous Basque patients with type 1 diabetes mellitus and celiac disease. Genes Immun 2006;7:550-554
36. Aly TA, Eller E, Ide A, Gowan K, Babu SR, Erlich HA, Rewers MJ, Eisenbarth GS, Fain PR. Multi-SNP analysis of MHC region: remarkable conservation of HLA-A1-B8-DR3 haplotype. Diabetes 2006;55:1265-1269
37. Bugawan TL, Klitz W, Alejandrino M, Ching J, Panelo A, Solfelix CM, Petrone A, Buzzetti R, Pozzilli P, Erlich HA. The association of specific HLA class I and II alleles with type 1 diabetes among Filipinos. Tissue Antigens 2002;59:452-469 (Pubitemid 35034465)
38. Santin I, Castellanos-Rubio A, Aransay AM, Gutierrez G, Gaztambide S, Rica I, Vicario JL, Noble JA, Castaño L, Bilbao JR. Exploring the diabetogenicity of the HLA-B18-DR3 CEH: independent association with T1D genetic risk close to HLA-DO. Genes Immun 2009;10:596-600
39. Snyder JA, Weston A, Tinkle SS, Demchuk E. Electrostatic potential on human leukocyte antigen: implications for putative mechanism of chronic beryllium disease. Environ Health Perspect 2003;111:1827-1834
40. Gaston JS, Goodall JC, Young JL, Young SP. Effect of polymorphism of the HLA-DPA1 chain on presentation of antigenic peptides. Hum Immunol 1997;54:40-47
41. Kishi H, Okumura A, Tong JJ, Sugiyama E, Matsuno H, Minowada J, Kanai T, Nishimura Y, Muraguchi A. A murine monoclonal antibody (928) recognizing a new epitope formed with a combination of HLA-DPA1*0201 and DPB1*0301 gene products. Hum Immunol 1997;56:114-124
42. Díaz G, Catálfamo M, Coiras MT, Alvarez AM, Jaraquemada D, Nombela C, Sánchez-Pérez M, Arroyo J. HLA-DPbeta residue 69 plays a crucial role in allorecognition. Tissue Antigens 1998;52:27-36
43. Lombardi G, Germain C, Uren J, Fiorillo MT, du Bois RM, Jones-Williams W, Saltini C, Sorrentino R, Lechler R. HLA-DP allele-specific T cell responses to beryllium account for DP-associated susceptibility to chronic beryllium disease. J Immunol 2001;166:3549-3555
44. Berretta F, Butler RH, Diaz G, Sanarico N, Arroyo J, Fraziano M, Aichinger G, Wucherpfennig KW, Colizzi V, Saltini C, Amicosante M. Detailed analysis of the effects of Glu/Lys beta69 human leukocyte antigen-DP polymorphism on peptide-binding specificity. Tissue Antigens 2003;62: 459-471
45. Hammer J, Gallazzi F, Bono E, Karr RW, Guenot J, Valsasnini P, Nagy ZA, Sinigaglia F. Peptide binding specificity of HLA-DR4 molecules: correlation with rheumatoid arthritis association. J Exp Med 1995;181: 1847-1855
46. Cucca F, Lampis R, Congia M, Angius E, Nutland S, Bain SC, Barnett AH, Todd JA. A correlation between the relative predisposition of MHC class II alleles to type 1 diabetes and the structure of their proteins. Hum Mol Genet 2001;10:2025-2037